| Net Cash Provided by (Used in) Operating Activities |
$88,715 |
USD |
32% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$190,000 |
USD |
-37% |
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$51,932 |
USD |
79% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
30,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
2,800,900 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$41,172 |
USD |
-11% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$788,175 |
USD |
15% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$788,175 |
USD |
15% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$2,221,109 |
USD |
-2.1% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$347 |
USD |
-83% |
Q2 2024 |
Q2 2025 |